Literature DB >> 9232204

Expression study of survival motor neuron gene in human fetal tissues.

G Novelli1, L Calzà, P Amicucci, L Giardino, M Pozza, V Silani, A Pizzuti, M Gennarelli, G Piombo, F Capon, B Dallapiccola.   

Abstract

In order to investigate the spinal muscular atrophy (SMA) disease processes, the expression of the survival motor neuron gene (SMN) has been analyzed in human fetal tissues using RT-PCR and in situ hybridization. These studies allowed the detection of SMN RNA in all the examined tissues, with no significant variation between different developmental stages. In particular, SMN mRNA was detected in spinal cord (dorsal and ventral portions), skeletal muscle, lung, heart, kidney, liver, and spleen. Moreover, RT-PCR studies demonstrated that the expression pattern of SMN isoforms was similar to that observed in adult tissues. The present data confirm a housekeeping role for the SMN protein and may have implications on the search for early therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9232204     DOI: 10.1006/bmme.1997.2590

Source DB:  PubMed          Journal:  Biochem Mol Med        ISSN: 1077-3150


  14 in total

1.  Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy.

Authors:  Kevin A Kaifer; Eric Villalón; Erkan Y Osman; Jacqueline J Glascock; Laura L Arnold; D D W Cornelison; Christian L Lorson
Journal:  JCI Insight       Date:  2017-03-09

Review 2.  Spinal muscular atrophy: mechanisms and therapeutic strategies.

Authors:  Christian L Lorson; Hansjorg Rindt; Monir Shababi
Journal:  Hum Mol Genet       Date:  2010-04-13       Impact factor: 6.150

3.  Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.

Authors:  Virginia B Mattis; Ravi Rai; Jinhua Wang; Cheng-Wei T Chang; Tristan Coady; Christian L Lorson
Journal:  Hum Genet       Date:  2006-09-02       Impact factor: 4.132

4.  Cell-specific survival motor neuron gene expression during human development of the central nervous system: implications for the pathogenesis of spinal muscular atrophy.

Authors:  E F Tizzano; C Cabot; M Baiget
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 5.  SMN-inducing compounds for the treatment of spinal muscular atrophy.

Authors:  Monique A Lorson; Christian L Lorson
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

6.  Intron 7 conserved sequence elements regulate the splicing of the SMN genes.

Authors:  Jordan T Gladman; Dawn S Chandler
Journal:  Hum Genet       Date:  2009-12       Impact factor: 4.132

Review 7.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

8.  Induction of full-length survival motor neuron by polyphenol botanical compounds.

Authors:  Mary S Sakla; Christian L Lorson
Journal:  Hum Genet       Date:  2007-10-26       Impact factor: 4.132

9.  Identification and characterization of the porcine (Sus scrofa) survival motor neuron (SMN1) gene: an animal model for therapeutic studies.

Authors:  Monique A Lorson; Lee D Spate; Randall S Prather; Christian L Lorson
Journal:  Dev Dyn       Date:  2008-08       Impact factor: 3.780

Review 10.  Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies.

Authors:  Raffaella Adami; Daniele Bottai
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.